Dr Reddy's launches generic arthritis drug Diclofenac Sodium in US market

Dr Reddy's Laboratories on Wednesday said it has launched over-the-counter Diclofenac Sodium topical gel, used for arthritis pain, in the US market

medicine, drugs, pharma
Press Trust of India New Delhi
1 min read Last Updated : Sep 09 2020 | 1:17 PM IST

Dr Reddy's Laboratories on Wednesday said it has launched over-the-counter Diclofenac Sodium topical gel, used for arthritis pain, in the US market.

The Hyderabad-based company's product is the generic version of Novartis Corporation's Voltaren gel.

"The launch of product is an important addition to our pain/analgesics portfolio of over-the-counter (OTC) products, and represents our continued commitment to the private label OTC space," Dr Reddy's Laboratories North America Generics CEO Marc Kikuchi said in a statement.

The company has partnered with Encube Ethicals to bring this product to market for the benefit of consumers, he added.

Diclofenac Sodium topical gel is used for temporary relief of arthritis pain in hand, wrist, elbow, foot, ankle and knee.

According to IRI data, the Voltaren brand had total retail sales of around USD 44 million since launch in May 2020.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Dr Reddy's Laboratories

First Published: Sep 09 2020 | 1:06 PM IST

Next Story